Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction
Cardiovascular Drugs and Therapy · 2024-12 · 38 (6) · 1187-1188
DOI: 10.1007/s10557-024-07607-8 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 15.07.2024. Verfasst von Ming Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, 252000, PR China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Liaocheng People's Hospital Dongchangfu Campus, Liaocheng, Shandong, 252000, PR China.
- The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital, Liaocheng, Shandong, 252000, PR China. xuli199102@163.com.
Zitieren
APA
Li, M., & Xu, L. (2024). Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction. Cardiovascular Drugs and Therapy, 38(6), 1187-1188. https://doi.org/10.1007/s10557-024-07607-8
Vancouver
Li M, Xu L. Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction. Cardiovascular Drugs and Therapy. 2024;38(6):1187-1188. doi:10.1007/s10557-024-07607-8
BibTeX
@article{Li2024,
author = {Li, Ming and Xu, Li},
title = {Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction},
journal = {Cardiovascular Drugs and Therapy},
year = {2024},
volume = {38},
number = {6},
pages = {1187--1188},
doi = {10.1007/s10557-024-07607-8}
}
EUVIMED